Crystal Hilger

Expression of PD-1 and PD-L1 in Anaplastic Thyroid Cancer Patients Treated With Multimodal Therapy: Results From a Retrospective Study

Ashish V. Chintakuntlawar, Kandelaria M. Rumilla, Carin Y. Smith et al. · The Journal of Clinical Endocrinology & Metabolism · 2017 · 132 citations · Full text

A Phase 2 Study of Pembrolizumab Combined with Chemoradiotherapy as Initial Treatment for Anaplastic Thyroid Cancer

Ashish V. Chintakuntlawar, Jun Yin, Robert L. Foote et al. · Thyroid · 2019 · 77 citations

Fosaprepitant-induced phlebitis: a focus on patients receiving doxorubicin/cyclophosphamide therapy

Alexis D. Leal, Kunal C. Kadakia, Sherry Looker et al. · Supportive Care in Cancer · 2014 · 49 citations · Full text

Fosaprepitant-induced Phlebitis, Medicine, Clinical Pharmacology +4

Salvage Lenvatinib Therapy in Metastatic Anaplastic Thyroid Cancer

Nicole M. Iñiguez‐Ariza, Mabel Ryder, Crystal Hilger et al. · Thyroid · 2017 · 37 citations

An analysis of fosaprepitant-induced venous toxicity in patients receiving highly emetogenic chemotherapy

Livia Hegerova, Alexis D. Leal, Darryl C. Grendahl et al. · Supportive Care in Cancer · 2014 · 32 citations · Full text

Emetogenic Chemotherapy, Oncology, Venous Disease +8